Detection of telomerase activity in patients with mycosis fungoides

Chinese Medical Sciences Journal

Volumn 18, Issue 2, 2003, Pages 124-127

  Zuolin, Ying ^a,b   Jianfang, Sun ^a   Shan, Liu ^a  

^a PEKING UNION MEDICAL COLLEGE   (China)

^b SHANGHAI FIRST PEOPLE S HOSPITAL   (China)

Author keywords

Mycosis fungoides; Telomerase

Indexed keywords

TELOMERASE;

ADULT; ARTICLE; BACTERIUM DETECTION; CELL IMMORTALIZATION; CELL PROLIFERATION; CHROMOSOMAL LOCALIZATION; CHROMOSOME LOSS; CLINICAL ARTICLE; DNA SEQUENCE; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; MALE; MYCOSIS FUNGOIDES; POLYMERASE CHAIN REACTION; SAMPLING; TANDEM REPEAT;

HUMANS; MYCOSIS FUNGOIDES; NEOPLASM STAGING; SKIN NEOPLASMS; TELOMERASE;

EID: 0038037962     PISSN: 10019294     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Blackburn EH. Structure and function of telomeres. Nature 1991; 350(6319): 569-73.
2. Harley CB. Telomere loss: mitotic clock or genetic time bomb. Mutat Res 1991; 256: 271-82.
3. Rhyu MS. Telomere, telomerase and immortality. J Natl Cancer Inst 1995; 87(12): 884-90.
4. Kim NW, Piatyszek MA, Prowse KR, et al. Specific association of human telomerase activity with immoral cells and cancer. Science 1994; 266(5193): 2011-15.
5. Hiyama E, Yokoyama T, Tastsumoto N, et al. Telomerase activity in gastric cancer. Cancer Res 1995; 55(15): 3258-62.
6. Yashima K, Litzky LA, Kaiser L, et al. Telomerase expression in respiratory epithelium during the multistage pathogenesis of lung carcinomas. Cancer Res 1997; 57(12): 2373-7.
7. Taylor RS, Ramirez RD, Ogoshi M, et al. Detection of telomerase activity in malignant and nonmalignant skin conditions. J Invest Dermatol 1996; 106(4): 759-65.
8. Kaida W, Marianne L, Karen B, et al. Telomerase activity and telomere length in lymphocytes from patients with cutaneous T-cell lymphoma. Cancer 1999; 86(6):1056-63.
9. Kyo S, Takakura M, Tanaka M, et al. Quantitative differences in telomerase activity among malignant, premalignant and benign ovarian lesions. Clin Cancer Res 1998; 4: 399-405.